Compare Analog Devices, Inc. (ADI) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Analog Devices, Inc. vs Illumina, Inc. — how do they compare? Analog Devices, Inc. trades at $389.54 (market cap $187.67B), while Illumina, Inc. trades at $193.06 (market cap $29.12B). The key difference: Analog Devices, Inc. is far larger — about 6.4× Illumina, Inc.'s market cap, and Analog Devices, Inc. pays a 1.14% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ADI | ILMN | |
|---|---|---|
Market Cap | $187.67B | $29.12B |
Sector | Technology | Health |
52-Week High | $445.48 | $205.10 |
52-Week Low | $225.20 | $91.00 |
Enterprise Value | $192.92B | $30.48B |
Dividend Yield | 1.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Analog Devices, Inc.
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
